FDA approves launch of “largest clinical trial to date” for tDCS depression treatment - NeuroNews International

Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation device to treat depression at home, has received full US Food and Drug Administration (FDA) investigational device exemption (IDE) to launch a US pivotal …

Flow headset Flow Neuroscience, which claims to be the creator of Europes first medically approved brain stimulation device to treat depression at home, has received full US Food and Drug Administra… [+3746 chars]

full article...